BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for PRINCIPIA BIOPHARMA INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-08-25 12:32 pm Unchanged | 2020-08-25 | 13D | PRINCIPIA BIOPHARMA INC PRNB | BIOTECHNOLOGY VALUE FUND L P | 5,231,900 15.700% | 0 (Unchanged) | Filing |
| 2020-08-19 1:49 pm Purchase | 2020-08-17 | 13G | PRINCIPIA BIOPHARMA INC PRNB | BIOTECHNOLOGY VALUE FUND L P | 5,231,900 15.700% | 3,515,166 (+204.76%) | Filing |
| 2020-02-14 3:26 pm Purchase | 2019-12-31 | 13G | PRINCIPIA BIOPHARMA INC PRNB | BIOTECHNOLOGY VALUE FUND L P | 1,716,734 5.200% | 79,884 (+4.88%) | Filing |